#

Small caps

: 1220
Immix initially focused on developing oncology and anti-inflammatory therapies / Photo: Shutterstock.com
Small Caps·
Immix Biopharma is targeting an $11 bln market. How much upside does the stock offer?
Companies whose management responds directly to analysts and investors questions show better performance. Photo: Chris Montgomery / Unsplash.com
Review·
"A premium for candor": how top executives' comments affect companies' share prices
Wizz Air withheld 2027 guidance due to uncertainty around the Iran conflict / Photo: Toni. M / Shutterstock.com
Small Caps·
Small caps last week: Record biotech IPO, Wizz Air's solid top line, SpaceX effect
Markets have been feverish all week, with the VIX fear index consolidating above 20. Photo: Shutterstock
Review·
An investment idea for all times, IPO of the year and how to keep emotions in check in the stock market
Rocket Lab is down 11% as of this writing on Friday, despite Nasdaqs decision to add the company to the Nasdaq 100 index / Photo: rocketlabcorp.com
Small Caps·
Space stocks open with big losses as SpaceX goes public
Forbrights platform ​spans middle-market lending, digital consumer banking, strategic advisory, and asset management services / Photo: Facebook / Forbright Bank
Small Caps·
+1
·
Forbright, bank of former Democratic presidential candidate, advances after IPO
Wizz Air said the Iran conflict had shaved EUR50 million from earnings in its fiscal full year, while promising to take advantage of market dislocations to push for growth / Photo: Facebook / Wizz Air
Small Caps·
Wizz Air reports higher revenue despite Middle East conflict; shares rising early
Biotech small caps are prone to sharp moves on clinical-trial results and other news flow events / Photo: Shutterstock.com
Small Caps·
FDA decisions and clinical data due by end-June for handful of biotech small caps
Pop Culture Group’s digital entertainment business continued to drive growth during the period, said the company / Photo: Unsplash / Zhiqiang Wang
Small Caps·
Chinese micro-cap media company Pop Culture quadruples on preliminary earnings
Parabilis Medicines raised nearly $745 million in an upsized U.S. IPO and private placement / Photo: Unsplash / to Mathurin NAPOLY / matnapo
Small Caps·
+1
·
Parabilis IPO: Innovative cancer drug developer debuts on the Nasdaq
Victorias Secret has recently changed its ticker symbol to VSXY, another step toward putting sexuality first in its new public strategy / Photo: Anton_Ivanov / Shutterstock.com
Small Caps·
Lessons from Victoria's Secret: How trying to please everyone cost a brand billions
Mondays 3,600% surge in Inno Holdings stock came after the firm announced a $3 million development services agreement with a Hong Kong-based AI service provider to build an AI-powered used mobile phone sales agent system / Photo: Unsplash / Andrey Matveev
Small Caps·
Micro-cap reseller of used electronics soars 3,600% in a day on AI announcement
Load more